Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more
Scientific production - Institute for Cancer Research
Professor Harald A. Stenmark, head of the "Cellular membrane dynamics" research group at the Department of Molecular Cell Biology at the Institute for Cancer Research, has been given the prestigious University of Oslo Research Research Award for 2018.
In their statement the prize committee wishes to acknowledge one of the University's most prominent researchers in cancer research and cell biology, who has built an internationally renowned research environment that delivers innovative and original research helping to put the University of Oslo on the world map.
The research award will be distributed during the annual UiO party on September 2nd. Prizes for education, communication and innovation will also be given out during this event, each of the four awards amounting to 250.000 NOK.
Therese Seierstad from Mona-Elisabeth Revheim's "Functional and Molecular Imaging" research group at the Division of Radiology and Nuclear Medicine was appointed "Researcher of the Month" for June 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). Her research is mostly focused on prostate cancer and breast cancer. As head of research at the division she is also involved in research projects not directly related to cancer treatment. Seierstad's work is presented in a feature article published on the home page of Helse Sør-Øst.
An article by senior scientist Lene Malerød and her co-workers in Kaisa Haglund’s project group shows how the mitotic spindle achieves its correct orientation during cell division.
The article ”Centrosomal ALIX regulates mitotic spindle orientation by modulating astral microtubule dynamics” was published online on June 1 in The EMBO Journal and elucidates a previously unrecognized biological role of the multifunctional adaptor protein ALIX during cell division. Specifically, ALIX is recruited to centrosomes, where it promotes correct mitotic spindle orientation at metaphase during both asymmetric and symmetric cell division, by facilitating the formation of astral microtubules.
In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly.
Six research groups were awarded for their excellent papers published during the second half-year of 2017 on May 25th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.